logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Awh Closes Acquisition Of Four Maryland Dispensaries

Apr 28, 2023•over 2 years ago

Acquiring Company

Ascend Wellness Holdings

Acquired Company

Curaleaf

MorristownNew YorkFarmingCannabisRetailHealth Care

Description

Ascend Wellness Holdings, Inc. ("AWH" or the "Company") (CSE: AAWH.U) (OTCQX: AAWH), a multi-state, vertically-integrated cannabis operator focused on bettering lives through cannabis, announced that yesterday it closed on the previously announced acquisition of four licensed dispensaries in Aberdeen, Crofton, Ellicott City, and Laurel under the names Nature's Medicines and True Wellness from Devi Holdings, Inc. ("Devi"). This marks the Company's expansion into Maryland, its seventh state, in primarily limited license markets across the Midwest and East Coast.

Company Information

Company

Ascend Wellness Holdings

Location

Morristown, New Jersey, United States

About

Ascend Wellness Holdings, Inc. (AWH) is a vertically integrated multistate cannabis operator with licenses and assets in Illinois, Michigan, Ohio, Massachusetts, New Jersey, Pennsylvania, and Maryland. AWH owns and operates 31 dispensaries and six state-of-the-art cultivation facilities, growing award-winning strains and producing a curated selection of products for retail and wholesale customers. AWH produces and distributes its in-house Simply Herb, Ozone, Ozone Reserve, Common Goods, Tunnel Vision, and Royale branded products. AWH also produces and distributes products on behalf of its brand partners including Miss Grass, Lowell Smokes, Flower by Edie Parker, 1906, and AiroPro.

Related People

Sign in to view contact details

Sign in to view contact details

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed